Details for Patent: 8,334,279
✉ Email this page to a colleague
Which drugs does patent 8,334,279 protect, and when does it expire?
Patent 8,334,279 protects AGAMREE and is included in one NDA.
This patent has forty-three patent family members in twenty countries.
Summary for Patent: 8,334,279
Title: | Non-hormonal steroid modulators of NF-κB for treatment of disease |
Abstract: | The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-κB for the treatment or prevention of muscular wasting disease, including muscular dystrophy. |
Inventor(s): | McCall John M., Hoffman Eric, Nagaraju Kanneboyina |
Assignee: | Validus Genetics |
Application Number: | US13327628 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 8,334,279
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catalyst Pharms | AGAMREE | vamorolone | SUSPENSION;ORAL | 215239-001 | Oct 26, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,334,279
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2009260471 | ⤷ Try a Trial | |||
Brazil | PI0909564 | ⤷ Try a Trial | |||
Canada | 2725008 | ⤷ Try a Trial | |||
China | 102076344 | ⤷ Try a Trial | |||
China | 103536599 | ⤷ Try a Trial | |||
China | 103739647 | ⤷ Try a Trial | |||
Denmark | 2278978 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |